Filing Details

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

GoodRx Holdings, Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

38246G108

(CUSIP Number)

Trevor Bezdek

c/o GoodRx Holdings, Inc.,

2701 Olympic Boulevard

Santa Monica, California 90404

(855) 268-2822

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

June 29, 2021

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.  ☐

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

 

 

 

*	The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 38246G108		13D		Page 1 of 4 pages

 

1		Names of Reporting Persons   Idea Men, LLC
2		Check the Appropriate Box if a Member of a Group (a)  ☒        (b)  ☐
3		SEC Use Only
4		Source of Funds (See Instructions)   OO
5		Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)   ☐
6		Citizenship or Place of Organization   Delaware
NUMBER OF SHARES  BENEFICIALLY   OWNED BY EACH REPORTING PERSON WITH				7		Sole Voting Power   53,835,217
				8		Shared Voting Power   0
				9		Sole Dispositive Power   53,835,217
				10		Shared Dispositive Power   0
11		Aggregate Amount Beneficially Owned by Each Reporting Person   53,835,217
12		Check if the Aggregate Amount in Row (11) Excludes Certain Shares   ☐
13		Percent of Class Represented by Amount in Row (11)   43.6%
14		Type of Reporting Person   OO (Limited Liability Company)

CUSIP No. 38246G108		13D		Page 2 of 4 pages

 

EXPLANATORY NOTE

This Amendment No. 1 to Schedule 13D (the Amendment) amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission (the SEC) on June 1, 2021 (as amended, the Schedule 13D), relating to the shares of Class A Common Stock, par value $0.0001 per share (the Class A Common Stock), of GoodRx Holdings, Inc., a Delaware corporation (the Issuer). Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D.

 

Item 5.

Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a) (b)

 

Amount beneficially owned: 53,835,217

 

Percent of Class: 43.6%

 

Number of shares the Reporting Person has:

 

Sole power to vote or direct the vote: 53,835,217

 

Shared power to vote: 0

 

Sole power to dispose or direct the disposition of: 53,835,217

 

Shared power to dispose or direct the disposition of: 0

The Reporting Person is the record holder of 53,835,217 shares of Class B Common Stock, which are convertible to shares of Class A Common Stock on a one-to-one basis. The above percentage is based on 69,555,726 shares of Class A Common Stock outstanding as of May 10, 2021, based on the Issuers Quarterly Report on Form 10-Q filed on May 14, 2021.

In addition, by virtue of the agreements made pursuant to the Stockholders Agreement, the Stockholders acknowledge and agree that they are acting as a group for purposes of Rule 13d-3 under the Exchange Act. Shares beneficially owned by the other Stockholders are not the subject of this Amendment and accordingly, none of the other Stockholders are included as reporting persons herein.

CUSIP No. 38246G108		13D		Page 3 of 4 pages

 

(c) Since the most recent filing on Schedule 13D, the Reporting Person disposed of 2,228,649 shares of Class A Common Stock in a series of open market transactions at prices ranging from $31.44 to $39.03 per share. Details by date, listing the number of shares of Class A Common Stock disposed of and the weighted average price per share are provided below.

 

Date		Equity Shares Disposed Of				Weighted Average Price per Share
June 24, 2021			163,571			$	38.5193
June 25, 2021			260,241			$	37.4118
June 28, 2021			124,973			$	37.3880
June 29, 2021			213,351			$	36.2134
June 30, 2021			275,412			$	35.9634
July 1, 2021			249,367			$	34.8808
July 2, 2021			135,732			$	34.0355
July 6, 2021			398,515			$	32.7733
July 7, 2021			337,286			$	32.1360
July 8, 2021			70,201			$	33.0216

 

(d)

None.

 

(e)	Not applicable.

CUSIP No. 38246G108		13D		Page 4 of 4 pages

 

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: July 16, 2021